Jan. 6, 2009 -- The FDA has approved a new prescription acne gel called Epiduo for use in patients 12 and older.
Epiduo, which is used once daily, combines two long-time acne treatments: benzoyl peroxide 2.5% and adapalene 0.1%. Adapalene is a retinoid sold generically and by the brand name Differin.
Galderma, the company that makes Epiduo, states in a news release that Epiduo is the "first and only" combination acne gel of its kind. Epiduo will be available in the first quarter of 2009, according to a Galderma news release.
Galderma announced Epiduo's approval today; FDA records show that the approval went through on Dec. 8, 2008.
Britain's terror threat level has been reduced to "severe" from…
Iraqi forces have taken another step toward wresting Mosul from ISIS.
Nyland the dog has his very own yearbook photo, after going to…